Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Alzheimer's & Dementia, 2024
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial

Brown R., Tozer D., Loubière L. et al.

Olink Target 96Neurovascular DiseasesPathophysiologySerum

Molecular Medicine, 2024
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

Patel M., Fraser D., Daley M. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Nature Genetics, 2024
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

Ghouse J., Sveinbjörnsson G., Vujkovic M. et al.

Olink Explore 3072/384HepatologyPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2024
Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes

Gurung R., Zheng H., Koh H. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade

Wyss N., Berner F., Walter V. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Diabetes Care, 2024
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes

Yao P., Iona A., Pozarickij A. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Neuro-Oncology, 2024
EDA2R reflects the acute brain response to cranial irradiation in liquid biopsies

Lastra Romero A., Seitz T., Zisiadis G. et al.

Olink Target 96 MouseOncologyNeurologyPatient StratificationPlasmaCSF

Clinica Chimica Acta, 2024
Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer

Feng T., Jie M., Deng K. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2024
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Coffey D., Osman K., Aleman A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

JID Innovations, 2024
Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis

Bao A., Ma E., Cornman H. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

Miyano T., Mikkaichi T., Nakamura K. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Muscle & Nerve, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

Lindborg S., Goyal N., Katz J. et al.

Olink Target 96NeurologyPathophysiologyCSF

Breast Cancer Research, 2024
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival

Karihtala P., Leivonen S., Puistola U. et al.

Olink Target 96OncologyPatient StratificationSerum

Cancer Discovery, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity

Glitza I., Seo Y., Spencer C. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Blood Advances, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia

Nilius H., Hamzeh-Cognasse H., Hastings J. et al.

Olink Target 96HematologyPatient StratificationSerum

Nature Immunology, 2024
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

Liew F., Efstathiou C., Fontanella S. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Scientific Reports, 2024
RSAD2 is abundant in atherosclerotic plaques and promotes interferon-induced CXCR3-chemokines in human smooth muscle cells

Hayderi A., Kumawat A., Shavva V. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

European Journal of Heart Failure, 2024
Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme

Ferreira J., Packer M., Sattar N. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Science Immunology, 2024
Tissue-specific nonheritable influences drive endometrial immune system variation

Bister J., Filipovic I., Sun D. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasmaSerum

Translational Vision Science & Technology, 2024
Serum Biomarkers of Vascular Involvement in Childhood Uveitis

Kouwenberg C., Kuiper J., de Boer J. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPatient StratificationSerum

3637 publications